ABSTRACT
Objective:To explore the prognostic value of serum CXCL12 and IL-33 levels in patients with acute ischemic stroke. Methods:From December 2014 to June 2016,the patients with acute ischemic stroke in our hospital as the case group(122 cases) and healthy volunteer were recruited as normal group ( 59 cases ) . According to the mRS scores patients were divided into favorable outcomes group(86 cases) and unfavorable outcomes group(36 cases). On admission the serum CXCL12 and IL-33 levels of objects were measured by ELISA. Receiver operating characteristic curve( ROC) and AUV were used to evaluate the prognostic value serum CXCL12 and IL-33 in patients with acute ischemic stroke. The serum CXCL12 levels were significantly higher in the patients with acute ischemic stroke compared to the control group[8. 0 ng/ml(IQR,6. 7-8. 9) VS 3. 0 ng/ml(IQR,2. 3-3. 8),P<0. 001],and serum IL-33 levels were also significantly higher than those in the control group [ 65. 25 ng/L ( IQR,56. 05-71. 08 ) VS 35. 30 ng/L (IQR,26. 73-42. 55),P<0. 001]. The serum CXCL12 levels were significantly lower in patients with a favorable outcome group[7. 4 ng/ml(IQR,6. 3-8. 3)] compared with patients with an unfavorable outcome group[9. 3 ng/ml(IQR,8. 3-11. 1)],and IL-33 levels were also significantly lower than that of unfavorable outcomes group[66. 81 ng/L(IQR,61. 12-73. 29)VS 55. 38 ng/L(IQR,46. 75-64. 71),P<0. 001] . Pearson correlation analysis showed that serum CXCL12 and IL-33 levels were respectively positively and negatively correlated with mRS score(r=0. 524,P<0. 001;r=-0. 443,P<0. 001). The serum CXCL12 and IL-33 levels as an indicator for prognosis of functional outcome. The area under the curve was 0. 835,0. 784 respectively. The sensitivity was 77. 8%,83. 4%respectively and specificity was 73. 3%,66. 7% respectively. Conclusion:Serum CXCL12 and IL-33 levels can be used as markers for the prognosis of patients with acute ischemic stroke.
ABSTRACT
Objective:To explore the prognostic value of serum CXCL12 and IL-33 levels in patients with acute ischemic stroke. Methods:From December 2014 to June 2016,the patients with acute ischemic stroke in our hospital as the case group(122 cases) and healthy volunteer were recruited as normal group ( 59 cases ) . According to the mRS scores patients were divided into favorable outcomes group(86 cases) and unfavorable outcomes group(36 cases). On admission the serum CXCL12 and IL-33 levels of objects were measured by ELISA. Receiver operating characteristic curve( ROC) and AUV were used to evaluate the prognostic value serum CXCL12 and IL-33 in patients with acute ischemic stroke. The serum CXCL12 levels were significantly higher in the patients with acute ischemic stroke compared to the control group[8. 0 ng/ml(IQR,6. 7-8. 9) VS 3. 0 ng/ml(IQR,2. 3-3. 8),P<0. 001],and serum IL-33 levels were also significantly higher than those in the control group [ 65. 25 ng/L ( IQR,56. 05-71. 08 ) VS 35. 30 ng/L (IQR,26. 73-42. 55),P<0. 001]. The serum CXCL12 levels were significantly lower in patients with a favorable outcome group[7. 4 ng/ml(IQR,6. 3-8. 3)] compared with patients with an unfavorable outcome group[9. 3 ng/ml(IQR,8. 3-11. 1)],and IL-33 levels were also significantly lower than that of unfavorable outcomes group[66. 81 ng/L(IQR,61. 12-73. 29)VS 55. 38 ng/L(IQR,46. 75-64. 71),P<0. 001] . Pearson correlation analysis showed that serum CXCL12 and IL-33 levels were respectively positively and negatively correlated with mRS score(r=0. 524,P<0. 001;r=-0. 443,P<0. 001). The serum CXCL12 and IL-33 levels as an indicator for prognosis of functional outcome. The area under the curve was 0. 835,0. 784 respectively. The sensitivity was 77. 8%,83. 4%respectively and specificity was 73. 3%,66. 7% respectively. Conclusion:Serum CXCL12 and IL-33 levels can be used as markers for the prognosis of patients with acute ischemic stroke.
ABSTRACT
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are characterized by abnormal deposition of alpha-synuclein aggregates in many regions of the central and peripheral nervous systems. Accumulating evidence suggests that the alpha-synuclein pathology initiates in a few discrete regions and spreads to larger areas in the nervous system. Recent pathological studies of PD patients have raised the possibility that the enteric nervous system is one of the initial sites of alpha-synuclein aggregation and propagation. Here, we evaluated the induction and propagation of alpha-synuclein aggregates in the enteric nervous system of the A53T alpha-synuclein transgenic mice after injection of human brain tissue extracts into the gastric walls of the mice. Western analysis of the brain extracts showed that the DLB extract contained detergent-stable alpha-synuclein aggregates, but the normal brain extract did not. Injection of the DLB extract resulted in an increased deposition of alpha-synuclein in the myenteric neurons, in which alpha-synuclein formed punctate aggregates over time up to 4 months. In these mice, inflammatory responses were increased transiently at early time points. None of these changes were observed in the A53T mice injected with saline or the normal brain extract, nor were these found in the wild type mice injected with the DLB extract. These results demonstrate that pathological alpha-synuclein aggregates present in the brain of DLB patient can induce the aggregation of endogenous alpha-synuclein in the myenteric neurons in A53T mice, suggesting the transmission of synucleinopathy lesions in the enteric nervous system.
Subject(s)
Animals , Humans , Mice , alpha-Synuclein , Brain , Dementia , Enteric Nervous System , Inflammation , Lewy Bodies , Mice, Transgenic , Nervous System , Neurons , Parkinson Disease , Peripheral Nervous System , Tissue ExtractsABSTRACT
Objective:To study new dosage form of Bingpeng powder referring to oversea patent. Methods: To disperse Bingpeng powder, adhesive and viscosity builders (such as gelatin, carboxymethylcellulose, hypromellose or carbomer), nonionic emulsifier (gluceryl monostearate) and white vaseline into liquid paraffin, stir to attain paste. The formulation was screened by adhesive strength, shape keeping characteristic and water asorbing value. Results: The better formulation: Bingpeng powder 5.0g, hypromellose 21.0g, carbomer 14g, gluceryl monostearate 3.0g, white vaseline 7.0g, liquid paraffin to 100.0g; the paste getting rabbits' artificial ulcers healed more quickly than powder does. Conclusion: The paste is applied more expediently and more effective for oral ulcer.